Recurrent urinary tract infections among women: Comparative effectiveness of 5 prevention and management strategies using a markov chain monte carlo model

Clinical Infectious Diseases

Volumn 58, Issue 2, 2014, Pages 147-160

  Eells, Samantha J ^a,b,c,d   Bharadwa, Kiran ^a   McKinnell, James A ^a,b,c   Miller, Loren G ^a,b,c  

^a LOS ANGELES BIOMEDICAL RESEARCH INSTITUTE   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Management; Recurrent; Urinary tract infection

Indexed keywords

CRANBERRY EXTRACT; ESTROGEN; NITROFURANTOIN;

ACUPUNCTURE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; CRANBERRY; DOCTOR PATIENT RELATION; ESTROGEN THERAPY; HEALTH CARE COST; HUMAN; INFECTION PREVENTION; META ANALYSIS; MONTE CARLO METHOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; PROGRAM EFFECTIVENESS; QUALITY OF LIFE; RECURRENT INFECTION; RISK REDUCTION; SELF CARE; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; URINARY TRACT INFECTION;

MANAGEMENT; RECURRENT; URINARY TRACT INFECTION;

ACUPUNCTURE; ANTI-BACTERIAL AGENTS; ESTROGENS; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES RESEARCH; HUMANS; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME; URINARY TRACT INFECTIONS; VACCINIUM MACROCARPON;

EID: 84891749772     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit646     Document Type: Article

References (69)

1. Foxman B, Barlow R, D'Arcy H, Gillespie B, Sobel JD. Urinary tract infection: Self-reported incidence and associated costs. Ann Epidemiol 2000; 10:509-15
2. Griebling TL. Urologic diseases in America project: Trends in resource use for urinary tract infections in women. J Urol 2005; 173:1281-7
3. Kozak LJ, DeFrances CJ, Hall MJ. National hospital discharge survey: 2004 annual summary with detailed diagnosis and procedure data. Vital Health Stat 13 2006(Oct):1-209
4. National Kidney and Urologic Diseases Information Clearinghouse. Kidney and urologic diseases statistics for the United States. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2010
5. Foxman B, Frerichs RR. Epidemiology of urinary tract infection: I. Diaphragm use and sexual intercourse. Am J Public Health 1985; 75:1308-13
6. Foxman B. Recurring urinary tract infection: Incidence and risk factors. Am J Public Health 1990; 80:331-3
7. Nicolle LE, Ronald AR. Recurrent urinary tract infection in adult women: Diagnosis and treatment. Infect Dis Clin North Am 1987; 1:793-806
8. Pfau A, Sacks T, Engelstein D. Recurrent urinary tract infections in premenopausal women: Prophylaxis based on an understanding of the pathogenesis. J Urol 1983; 129:1153-7
9. Walker EB, Barney DP, Mickelsen JN, Walton RJ, Mickelsen RA Jr. Cranberry concentrate: UTI prophylaxis. J Fam Pract 1997; 45:167-8
10. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol 2002; 9:1558-62
11. Stamm WE, Counts GW, Wagner KF, et al. Antimicrobial prophylaxis of recurrent urinary tract infections: A double-blind, placebo-controlled trial. Ann Intern Med 1980; 92:770-5
12. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med 1993; 329:753-6
13. Raz R, Colodner R, Rohana Y, et al. Effectiveness of estriol-containing vaginal pessaries and nitrofurantoin macrocrystal therapy in the prevention of recurrent urinary tract infection in postmenopausal women. Clin Infect Dis 2003; 36:1362-8
14. Privette M, Cade R, Peterson J, Mars D. Prevention of recurrent urinary tract infections in postmenopausal women. Nephron 1988; 50:24-7
15. Pinggera GM, Feuchtner G, Frauscher F, et al. Effects of local estrogen therapy on recurrent urinary tract infections in young females under oral contraceptives. Eur Urol 2005; 47:243-9
16. McMurdo ME, Argo I, Phillips G, Daly F, Davey P. Cranberry or trimethoprim for the prevention of recurrent urinary tract infections? A randomized controlled trial in older women. J Antimicrob Chemother 2009; 63:389-95
17. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001; 322:1571
18. Eriksen B. A randomized, open, parallel-group study on the preventive effect of an estradiol-releasing vaginal ring (Estring) on recurrent urinary tract infections in postmenopausal women. Am J Obstet Gynecol 1999; 180:1072-9
19. Brumfitt W, Smith GW, Hamilton-Miller JM, Gargan RA. A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections. J Antimicrob Chemother 1985; 16:111-20
20. Brumfitt W, Hamilton-Miller JM, Walker S, Roberts D. Cefaclor as a prophylactic agent for recurrent urinary infections: A comparative trial with macrocrystalline nitrofurantoin. Drugs Exp Clin Res 1992; 18: 239-44
21. Brumfitt W, Hamilton-Miller JM, Smith GW, al-Wali W. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women. Q J Med 1991; 81:811-20
22. Brumfitt W, Hamilton-Miller JM. A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection. Infection 1995; 23:98-102
23. Brumfitt W, Cooper J, Hamilton-Miller JM. Prevention of recurrent urinary infections in women: A comparative trial between nitrofurantoin and methenamine hippurate. J Urol 1981; 126:71-4
24. Aune A, Alraek T, LiHua H, Baerheim A. Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women. Scand J Prim Health Care 1998; 16:37-9
25. Alraek T, Soedal LI, Fagerheim SU, Digranes A, Baerheim A. Acupuncture treatment in the prevention of uncomplicated recurrent lower urinary tract infections in adult women. Am J Public Health 2002; 92:1609-11
26. Gupta K, Hooton TM, Roberts PL, Stamm WE. Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women. Ann Intern Med 2001; 135:9-16
27. Schaeffer AJ, Stuppy BA. Efficacy and safety of self-start therapy in women with recurrent urinary tract infections. J Urol 1999; 161:207-11
28. Wong ES, McKevitt M, Running K, Counts GW, Turck M, Stamm WE. Management of recurrent urinary tract infections with patient-Administered single-dose therapy. Ann Intern Med 1985; 102:302-7
29. National Institute for Health and Care Excellence. Measuring effectiveness and cost effectiveness: The QALY. Available at: Http://www.nice. org.uk/newsroom/features/measuringeffectivenessandcosteffectiveness thmeasu.jsp. Accessed 5 November 2010
30. Le TP, Miller LG. Empirical therapy for uncomplicated urinary tract infections in an era of increasing antimicrobial resistance: A decision and cost analysis. Clin Infect Dis 2001; 33:615-21
31. Perfetto EM, Gondek K. Escherichia coli resistance in uncomplicated urinary tract infection: A model for determining when to change firstline empirical antibiotic choice. Manag Care Interface 2002; 15:35-42
32. McKinnell JA, Stollenwerk NS, Jung CW, Miller LG. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clinic proceedings. Mayo Clinic 2011; 86:480-8
33. Rosenberg M. Pharmacoeconomics of treating uncomplicated urinary tract infections. Int J Antimicrob Agents 1999; 11:247-51. ; discussion 261-4
34. Barry HC, Ebell MH, Hickner J. Evaluation of suspected urinary tract infection in ambulatory women: A cost-utility analysis of office-based strategies. J Fam Pract 1997; 44:49-60
35. Eron LJ, Passos S. Early discharge of infected patients through appropriate antibiotic use. Arch Intern Med 2001; 161:61-5
36. Benoit G, Yataghene Y, Bensadoun H, et al. Acute pyelonephritis in women. Short-Term hospitalization [in French]. Presse Med 1993; 22: 1724-8
37. Bailey R, Lynn K, Robson R, Peddie B, Smith A. Comparison of ciprofloxacin and netilmicin for the treatment of acute pyelonephritis. N Z Med J 1992; 105:102-3
38. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29:745-58
39. Stamm WE, McKevitt M, Roberts PL, White NJ. Natural history of recurrent urinary tract infections in women. Rev Infect Dis 1991; 13: 77-84
40. Flach SD, Longenecker JC, Tape TG, Bryan TJ, Parenti C, Wigton RS. The relationship between treatment objectives and practice patterns in the management of urinary tract infections. Med Decis Making 2003; 23:131-9
41. Dans PE, Klaus B. Dysuria in women. Johns Hopkins Med J 1976; 138:13-18
42. Komaroff AL, Pass TM, McCue JD, Cohen AB, Hendricks TM, Friedland G. Management strategies for urinary and vaginal infections. Arch Intern Med 1978; 138:1069-73
43. Echols RM, Tosiello RL, Haverstock DC, Tice AD. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis 1999; 29:113-9
44. Cunha BA. Intravenous-To-oral antibiotic switch therapy. A cost-effective approach. Postgrad Med 1997; 101:111-2, 115-8, 122-3 passim
45. Henry NK, Schultz HJ, Grubbs NC, Muller SM, Ilstrup DM, Wilson WR. Comparison of ciprofloxacin and co-Trimoxazole in the treatment of uncomplicated urinary tract infection in women. J Antimicrob Chemother 1986; 18(suppl D):103-6
46. Iravani A, Klimberg I, Briefer C, Munera C, Kowalsky SF, Echols RM. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-Trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother 1999; 43(suppl A):67-75
47. Grubbs NC, Schultz HJ, Henry NK, Ilstrup DM, Muller SM, Wilson WR. Ciprofloxacin versus trimethoprim-sulfamethoxazole: Treatment of community-Acquired urinary tract infections in a prospective, controlled, double-blind comparison. Mayo Clin Proc 1992; 67: 1163-8
48. Malinverni R, Glauser MP. Comparative studies of fluoroquinolones in the treatment of urinary tract infections. Rev Infect Dis 1988; 10(suppl 1): S153-63
49. American Hospital Association. Hospital statistics 2007 edition. Chicago: American Hospital Association, 2007
50. Centers for Medicare and Medicaid Services. Physician fee schedule look-up tool. Available at: Http://www.cms.hhs.gov/PFSlookup/02- PFSSearch.asp-TopOfPage. Accessed 17 March 2008
51. Neuner J, Hamel M, Phillips R, Bona K, Aronson M. Diagnosis and management of adults with pharyngitis. A cost-effectiveness analysis. Ann Intern Med 2003; 139:113-22
52. Rubin N, Foxman B. The cost-effectiveness of placing urinary tract infection treatment over the counter. J Clin Epidemiol 1996; 49: 1315-21
53. Sobel J, Wiesenfeld H, Martens M, et al. Maintenance fluconazole therapy for recurrent vulvovaginal candidasis. N Engl J Med 2004; 351:876-83
54. Kaplan RM, Atkins CJ, Timms R. Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. J Chronic Dis 1984; 37:85-95
55. Talan D, Stamm W, Hooton T, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: A randomized trial. JAMA 2000; 283:1583-90
56. McCarty J, Richard G, Huck W, et al. A randomized trial of shortcourse ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Am J Med 1999; 106:292-9
57. Henry D, Bettis R, Riffer E, et al. Comparison of once-daily extendedrelease ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther 2002; 24:2088-103
58. Hooton T, Winter C, Tiu F, Stamm W. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA 1995; 273:41-5
59. Spencer R, Moseley D, Greensmith M. Nitrofurantoin modified release versus trimethoprim or co-Trimoxazole in the treatment of uncomplicated urinary tract infection in general practice. J Antimicrob Chemother 1994; 33:121-9
60. Stein G. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther 1999; 21:1864-72 2010 Red Book. 114th ed. Montvale, NJ: Medical Economics Company, 2010
61. Takahashi S, Hirose T, Satoh T, et al. Efficacy of a 14-day course of oral ciprofloxacin therapy for acute uncomplicated pyelonephritis. J Infect Chemother 2001; 7:255-57
62. Jepson RG, Craig JC. A systematic review of the evidence for cranberries and blueberries in UTI prevention. Mol Nutr Food Res 2007; 51: 738-45
63. Barbosa-Cesnik C, Brown MB, Buxton M, Zhang L, DeBusscher J, Foxman B. Cranberry juice fails to prevent recurrent urinary tract infection: Results from a randomized placebo-controlled trial. Clin Infect Dis 2011; 52:23-30
64. Stapleton AE, Dziura J, Hooton TM, et al. Recurrent urinary tract infection and urinary Escherichia coli in women ingesting cranberry juice daily: A randomized controlled trial. Mayo Clin Proc 2012; 87: 143-50
65. Beerepoot MA, ter Riet G, Nys S, et al. Cranberries vs antibiotics to prevent urinary tract infections: A randomized double-blind noninferiority trial in premenopausal women. Arch Intern Med 2011; 171:1270-8
66. Perrotta C, Aznar M, Mejia R, Albert X, Ng CW. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008; CD005131
67. Cardozo L, Lose G, McClish D, Versi E, de Koning Gans H. A systematic review of estrogens for recurrent urinary tract infections: Third report of the hormones and urogenital therapy (HUT) committee. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12:15-20
68. Baerheim A, Larsen E, Digranes A. Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women. Scand J Prim Health Care 1994; 12:239-43
69. Beerepoot MA, ter Riet G, Nys S, et al. Lactobacilli vs antibiotics to prevent urinary tract infections: A randomized, double-blind, noninferiority trial in postmenopausal women. Arch Intern Med 2012; 172: 704-12